BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit NEW YORK, Oct. ...

BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit NEW YORK, Oct. 3, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the "Class Period"), of the important November 3, 2026 lead plaintiff deadline. So what: If you purchased Beta Bionics common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.